TrialHepatology (Baltimore, Md.)2023

Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study.

Mitesh J Borad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.